Prosepective,Randomized, controlled study enrolling full termed parturients admitted for vaginal delivery. At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups: * ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the level of the 3 rd Lumbar transverse process. * Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural analgesia.
Prosepective,Randomized, controlled study enrolling full termed parturients admitted for vaginal delivery. At the sencond stage of labor: 3cm of cervix dilatation, patients will be randomized in 2 groups: * ESP group: patients will receive ultrasound guided, bilateral ESP Block performed at the level of the 3 rd Lumbar transverse process. * Epidural Analgesia Group: Patients will have a classic lumbar continuous epidural analgesia. For the first group: 20 ml of 0,375% isobaric Bupivacain solution will be injected bilaterally under ultrasound direct vision. Concerning the second group, patients will have a continuous injection of 0,125% Bupivacain solution associated to 0,25 mcg of Sufentanil/ml through an epidural catheter in the L3-L4 or L4-L5 intervertebral space. For the 2 groups, analgesia will be assessed during all the labor period hourly using the Visual Analog pain Score (VAS).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
50
bilateral lumbar ESP block using 0.375% Bupivacain
Continuous Lumbar Epidural analgesia With 0,125% Bupivacain+0,25 mcg/ml Sufentanil
Analgesia during labor
analgesia assessed using VAScore
Time frame: change in VAS score 1 hour after the beginning of labor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.